Solid dispersion approach for overcoming bioavailability problems due to polymorphism of nabilone, a cannabinoid derivative.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001682:Biological Availability; D002214:Capsules; D004285:Dogs; D013759:Dronabinol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D004355:Drug Stability; D011205:Povidone; D012995:Solubility
D014151:Anti-Anxiety Agents; D002214:Capsules; C011941:nabilone; D013759:Dronabinol; D011205:Povidone